Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
ImmuniCell® in Patients With Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE2
Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot Project
- Status
- COMPLETED
- Phase
- N/A
Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation
- Status
- UNKNOWN
- Phase
- PHASE3
Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²)
- Status
- COMPLETED
- Phase
- N/A
Marker Guided Breathhold Radiotherapy in NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Micro RNA Genetic Signature in NSCLC Egyptian Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of AMG 228 to Treat Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression
- Status
- TERMINATED
- Phase
- N/A
A Study of BGB324 (Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Stereotactic Ablative Radiotherapy for Oligometastatic Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC
- Status
- COMPLETED
- Phase
- PHASE2